EUVIMEDEUVIMED entdecken
Übersichtsarbeit

New perspectives on chagasic cardiomyopathy: A narrative review of genetics, magnetic resonance imaging and therapeutic alternatives

Jose Martin Velasco Hurtado iD, Dayannara Quispe Zavala iD, Chiara Vilela Luchini iD, Renzo Reineiro Rosales Gutiérrez iD

Medwave · 10.08.2026 · 26 (07) · e3236-e3236

DOI: 10.5867/medwave.2026.07.3236 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medwave, online erschienen am 10.08.2026. Verfasst von Jose Martin Velasco Hurtado und 3 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Medicina, Universidad Ricardo Palma, Lima, Perú. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Chagas Cardiomyopathy, Trypanocidal Agents.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chagasic cardiomyopathy is the chronic manifestation of American trypanosomiasis. In endemic regions of Peru, delayed diagnosis remains a major public health concern. This review analyzes recent evidence (2020 to 2026) regarding the impact of genetic variants on severity, the utility of cardiac magnetic resonance imaging, and the efficacy of trypanocidal and advanced support treatment. A search was conducted in PubMed and Scopus, prioritizing clinical trials and meta-analyses. Current data challenge the direct relationship between parasite lineage and cardiac severity, highlighting the host inflammatory response as the primary driver. Diagnostically, cardiac magnetic resonance imaging surpassed echocardiography in identifying early fibrosis and defining arrhythmic risk. Regarding therapy, benznidazole use during the indeterminate phase reduced the risk of clinical progression (Relative Risk (RR) 0.35), challenging traditional palliative approaches. In conclusion, current evidence repositions etiological treatment as a viable preventive strategy and underscores the importance of cardiac magnetic resonance imaging for early clinical management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Magnetic Resonance ImagingChagas CardiomyopathyTrypanocidal AgentsHumansNitroimidazolesDisease ProgressionSeverity of Illness IndexPeruEchocardiography

Stichwörter der Autor:innen

BiomarcadoresBiomarkersCardiomiopatía ChagásicaChagas CardiomyopathyHeart FailureImagen por Resonancia MagnéticaInsuficiencia CardíacaMagnetic Resonance ImagingTrypanosoma cruzi

Substanzen

Trypanocidal AgentsNitroimidazolesbenzonidazole

Autor:innen und Institutionen

  • Facultad de Medicina, Universidad Ricardo Palma, Lima, Perú.
  • Línea de Investigación en Atención Primaria de Salud, CPC SOCIMEP, Perú.
  • Servicio de Cardiología, Hospital Nacional Dos de Mayo, Lima, Perú.

ORCID-Profile: Jose Martin Velasco Hurtado, Dayannara Quispe Zavala, Chiara Vilela Luchini, Renzo Reineiro Rosales Gutiérrez

Zitieren

APA

Velasco Hurtado, J. M., Quispe Zavala, D., Vilela Luchini, C., & Rosales Gutiérrez, R. R. (2026). New perspectives on chagasic cardiomyopathy: A narrative review of genetics, magnetic resonance imaging and therapeutic alternatives. Medwave, 26(07), e3236-e3236. https://doi.org/10.5867/medwave.2026.07.3236

Vancouver

Velasco Hurtado JM, Quispe Zavala D, Vilela Luchini C, Rosales Gutiérrez RR. New perspectives on chagasic cardiomyopathy: A narrative review of genetics, magnetic resonance imaging and therapeutic alternatives. Medwave. 2026;26(07):e3236-e3236. doi:10.5867/medwave.2026.07.3236

BibTeX
@article{VelascoHurtado2026,
  author = {Velasco Hurtado, Jose Martin and Quispe Zavala, Dayannara and Vilela Luchini, Chiara and Rosales Gutiérrez, Renzo Reineiro},
  title = {New perspectives on chagasic cardiomyopathy: A narrative review of genetics, magnetic resonance imaging and therapeutic alternatives},
  journal = {Medwave},
  year = {2026},
  volume = {26},
  number = {07},
  pages = {e3236--e3236},
  doi = {10.5867/medwave.2026.07.3236}
}
Kostenlos starten →